{"id":2119,"date":"2025-05-19T11:20:59","date_gmt":"2025-05-19T09:20:59","guid":{"rendered":"https:\/\/dextechmedical.com\/?p=2119"},"modified":"2025-05-19T11:08:59","modified_gmt":"2025-05-19T09:08:59","slug":"dextech-medicals-patent-application-regarding-gmp-manufacturing-of-osteodex-is-approved","status":"publish","type":"post","link":"https:\/\/dextechmedical.com\/en\/dextech-medicals-patent-application-regarding-gmp-manufacturing-of-osteodex-is-approved\/","title":{"rendered":"DexTech Medical’s patent application regarding GMP manufacturing of OsteoDex is approved"},"content":{"rendered":"

OsteoDex is DexTech’s lead candidate for the treatment of castration-resistant prostate cancer and has completed clinical phase 2. In October 2023, the Company filed a patent application with the EPO (European patent office, application No. 23203437.1).<\/p>\n

The application concerned GMP (Good Manufacturing Practice) manufacturing of OsteoDex. The application has now been approved, and a patent has been granted. The patent is of great importance for the continued clinical development of OsteoDex and future market exclusivity. The patent is valid until 2045 and is very positive for the Company’s partnership\/out-licensing talks.<\/p>\n

“This is gratifying news as OsteoDex’s patent protection is a key factor in our partnership discussions. Licensees have a requirement for a longer period of market exclusivity after registration, which we meet with the patent by far,” says CEO Anders R Holmberg<\/em><\/p>\n

For more information about DexTech, please contact:<\/strong><\/p>\n

G\u00f6sta Lundgren \u2013 CFO<\/p>\n

DexTech Medical AB<\/p>\n

Phone: +46 (0) 707104788<\/p>\n

E-mail: gosta.lundgren@dextechmedical.com<\/p>\n

This information is information that DexTech Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on May 19, 2025.<\/em><\/p>\n

250519 – PR – DexTech Medical’s patent application regarding GMP manufacturing of OsteoDex is approved<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

OsteoDex is DexTech’s lead candidate for the treatment of castration-resistant prostate cancer and has completed clinical phase 2. In October 2023, the Company filed a patent application with the EPO […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[3],"tags":[],"class_list":["post-2119","post","type-post","status-publish","format-standard","hentry","category-okategoriserade-en"],"acf":[],"yoast_head":"\nDexTech Medical's patent application regarding GMP manufacturing of OsteoDex is approved | DexTech<\/title>\n<meta name=\"description\" content=\"OsteoDex is DexTech's lead candidate for the treatment of castration-resistant prostate cancer and has completed clinical phase 2. In October 2023, the\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dextechmedical.com\/dextech-medicals-patentansokan-avseende-gmp-tillverkning-av-osteodex-ar-godkand\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"DexTech Medical's patent application regarding GMP manufacturing of OsteoDex is approved | DexTech\" \/>\n<meta property=\"og:description\" content=\"OsteoDex is DexTech's lead candidate for the treatment of castration-resistant prostate cancer and has completed clinical phase 2. In October 2023, the\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dextechmedical.com\/dextech-medicals-patentansokan-avseende-gmp-tillverkning-av-osteodex-ar-godkand\/\" \/>\n<meta property=\"og:site_name\" content=\"DexTech\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-19T09:20:59+00:00\" \/>\n<meta name=\"author\" content=\"G\u00f6sta Lundgren\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"G\u00f6sta Lundgren\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/dextechmedical.com\/dextech-medicals-patentansokan-avseende-gmp-tillverkning-av-osteodex-ar-godkand\/\",\"url\":\"https:\/\/dextechmedical.com\/dextech-medicals-patentansokan-avseende-gmp-tillverkning-av-osteodex-ar-godkand\/\",\"name\":\"DexTech Medical's patent application regarding GMP manufacturing of OsteoDex is approved | DexTech\",\"isPartOf\":{\"@id\":\"https:\/\/dextechmedical.com\/#website\"},\"datePublished\":\"2025-05-19T09:20:59+00:00\",\"author\":{\"@id\":\"https:\/\/dextechmedical.com\/#\/schema\/person\/7d6388cae097fcab5953ef5d1733040c\"},\"description\":\"OsteoDex is DexTech's lead candidate for the treatment of castration-resistant prostate cancer and has completed clinical phase 2. In October 2023, the\",\"breadcrumb\":{\"@id\":\"https:\/\/dextechmedical.com\/dextech-medicals-patentansokan-avseende-gmp-tillverkning-av-osteodex-ar-godkand\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/dextechmedical.com\/dextech-medicals-patentansokan-avseende-gmp-tillverkning-av-osteodex-ar-godkand\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/dextechmedical.com\/dextech-medicals-patentansokan-avseende-gmp-tillverkning-av-osteodex-ar-godkand\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/dextechmedical.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"DexTech Medical’s patent application regarding GMP manufacturing of OsteoDex is approved\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/dextechmedical.com\/#website\",\"url\":\"https:\/\/dextechmedical.com\/\",\"name\":\"DexTech\",\"description\":\"Ett svenskt forskningsf\u00f6retag specialiserat p\u00e5 urologisk onkologi fr\u00e4mst prostatacancer\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/dextechmedical.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/dextechmedical.com\/#\/schema\/person\/7d6388cae097fcab5953ef5d1733040c\",\"name\":\"G\u00f6sta Lundgren\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/dextechmedical.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/5e00bd305cedebf5b9069290209926ac27dd0b062e7cdfd04870526f70b02470?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/5e00bd305cedebf5b9069290209926ac27dd0b062e7cdfd04870526f70b02470?s=96&d=mm&r=g\",\"caption\":\"G\u00f6sta Lundgren\"},\"sameAs\":[\"https:\/\/dextechmedical.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"DexTech Medical's patent application regarding GMP manufacturing of OsteoDex is approved | DexTech","description":"OsteoDex is DexTech's lead candidate for the treatment of castration-resistant prostate cancer and has completed clinical phase 2. In October 2023, the","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dextechmedical.com\/dextech-medicals-patentansokan-avseende-gmp-tillverkning-av-osteodex-ar-godkand\/","og_locale":"en_US","og_type":"article","og_title":"DexTech Medical's patent application regarding GMP manufacturing of OsteoDex is approved | DexTech","og_description":"OsteoDex is DexTech's lead candidate for the treatment of castration-resistant prostate cancer and has completed clinical phase 2. In October 2023, the","og_url":"https:\/\/dextechmedical.com\/dextech-medicals-patentansokan-avseende-gmp-tillverkning-av-osteodex-ar-godkand\/","og_site_name":"DexTech","article_published_time":"2025-05-19T09:20:59+00:00","author":"G\u00f6sta Lundgren","twitter_misc":{"Written by":"G\u00f6sta Lundgren","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/dextechmedical.com\/dextech-medicals-patentansokan-avseende-gmp-tillverkning-av-osteodex-ar-godkand\/","url":"https:\/\/dextechmedical.com\/dextech-medicals-patentansokan-avseende-gmp-tillverkning-av-osteodex-ar-godkand\/","name":"DexTech Medical's patent application regarding GMP manufacturing of OsteoDex is approved | DexTech","isPartOf":{"@id":"https:\/\/dextechmedical.com\/#website"},"datePublished":"2025-05-19T09:20:59+00:00","author":{"@id":"https:\/\/dextechmedical.com\/#\/schema\/person\/7d6388cae097fcab5953ef5d1733040c"},"description":"OsteoDex is DexTech's lead candidate for the treatment of castration-resistant prostate cancer and has completed clinical phase 2. In October 2023, the","breadcrumb":{"@id":"https:\/\/dextechmedical.com\/dextech-medicals-patentansokan-avseende-gmp-tillverkning-av-osteodex-ar-godkand\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dextechmedical.com\/dextech-medicals-patentansokan-avseende-gmp-tillverkning-av-osteodex-ar-godkand\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/dextechmedical.com\/dextech-medicals-patentansokan-avseende-gmp-tillverkning-av-osteodex-ar-godkand\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dextechmedical.com\/en\/"},{"@type":"ListItem","position":2,"name":"DexTech Medical’s patent application regarding GMP manufacturing of OsteoDex is approved"}]},{"@type":"WebSite","@id":"https:\/\/dextechmedical.com\/#website","url":"https:\/\/dextechmedical.com\/","name":"DexTech","description":"Ett svenskt forskningsf\u00f6retag specialiserat p\u00e5 urologisk onkologi fr\u00e4mst prostatacancer","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dextechmedical.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/dextechmedical.com\/#\/schema\/person\/7d6388cae097fcab5953ef5d1733040c","name":"G\u00f6sta Lundgren","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/dextechmedical.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/5e00bd305cedebf5b9069290209926ac27dd0b062e7cdfd04870526f70b02470?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/5e00bd305cedebf5b9069290209926ac27dd0b062e7cdfd04870526f70b02470?s=96&d=mm&r=g","caption":"G\u00f6sta Lundgren"},"sameAs":["https:\/\/dextechmedical.com"]}]}},"_links":{"self":[{"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/posts\/2119","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/comments?post=2119"}],"version-history":[{"count":2,"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/posts\/2119\/revisions"}],"predecessor-version":[{"id":2124,"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/posts\/2119\/revisions\/2124"}],"wp:attachment":[{"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/media?parent=2119"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/categories?post=2119"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dextechmedical.com\/en\/wp-json\/wp\/v2\/tags?post=2119"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}